From Lab to Leak: Why Henlius’ EU Approval Exposes Pharma’s Darkest Cybersecurity Secret + Video
Introduction: The European Commission’s recent approval of Henlius’ serplulimab (HETRONIFLY) for advanced squamous non-small cell lung cancer marks a significant […]









